Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling of miRNA expression in immune thrombocytopenia patients before and after Qishunbaolier (QSBLE) treatment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2015
Same author

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

European journal of gynaecological oncology·2013
Same author

Short communication: effect of difructose anhydride III on serum immunoglobulin G concentration in newborn calves.

Journal of dairy science·2012
Same author

Complications and obstetric outcomes after laser conization during pregnancy.

European journal of gynaecological oncology·2010
Same author

Transmission of kilowatt-class CO(2) laser light through dielectric-coated metallic hollow waveguides for material processing.

Applied optics·2010
Same author

Dielectric-coated metallic hollow waveguide for 3-microm Er:YAG, 5-microm CO, and 10.6-,microm CO(2) laser light transmission.

Applied optics·2010

Related Experiment Video

Updated: Jul 15, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Versican expression in human cervical cancer.

J Kodama1, Hasengaowa, T Kusumoto

  • 1Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. kodama@cc.okayama-u.ac.jp

European Journal of Cancer (Oxford, England : 1990)
|April 21, 2007
PubMed
Summary

High versican expression in cervical cancer correlates with increased tumor invasion and metastasis. This finding suggests versican may serve as a key biomarker for predicting poor prognosis in patients with cervical cancer.

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: Jul 15, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Versican is implicated in tumor invasion and metastasis.
  • Limited characterization of versican expression in cervical cancer exists.

Purpose of the Study:

  • To investigate versican protein expression in human cervical cancers.
  • To analyze the correlation between versican expression and clinicopathological features and patient outcomes.

Main Methods:

  • Immunohistochemical analysis of versican protein expression.
  • Study included 174 cases of human cervical cancer.
  • Correlation analysis with clinicopathological features and patient survival.

Main Results:

  • Stromal versican expression was significantly higher in patients with lymph node metastasis (p<0.0001).
  • Epithelial versican expression was elevated in non-squamous cell carcinoma, lymph-vascular space invasion, lymph node metastasis, and ovarian metastasis.
  • High epithelial versican expression independently predicted poor disease-free survival.

Conclusions:

  • Versican enrichment in tumor tissue is associated with cervical cancer progression.
  • Versican expression serves as a potential indicator of poor prognosis in cervical cancer patients.